Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to do an AMD stock analysis and talk about the risks and upside potential of AMD stock

1 extracted signal · 1 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
05 Nov 2025, 03:37 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Friends! In this video, I'm going to do an AMD stock analysis and talk about the risks and upside potential of AMD stock
Source overview

AI-generated source summary

The video provides a fundamental analysis of AMD's stock, referring to its Q3 2025 revenue growth of 36% year-over-year reaching $9.2 billion, and client and gaming segment experiencing a 73% year-over-year revenue increase. It mentions AMD has a partnership with Open AI and many others. Quarter on quarter data centre revenue is at 22% and revenue growth is at 32%. The video suggests that despite the stock trading at almost 50 times 2026 earnings, with estimated 54% earnings growth in 2026, and average multiple of 35, there's still 105% upside to $513 and projects $183 per share if buying with margin of safety over the next five years.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
1
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
100%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.9
Tracked signals
355
Historical success
34.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail